Long-term treatment with acylated analogs of apelin-13 amide [particularly pGlu(Lys8GluPAL)apelin-13] ameliorated diet induced obesity-diabetes in mice and improved lipid profile (O’Harte et al., 2018a). Here, APLN is linked to obesity disorder.